Rookie quarterback Riley Leonard showed that he belongs after his first NFL start against the Houston Texans in the Indianapolis Colts’ 2025-26 regular season finale. A sixth-round draft selection ...

Longtime Black Sabbath guitarist Tony Iommi has some big 2026 news to share as he reflected on all the big happenings in his world over the last 12 months for his New Year video message. The guitar ...

Manchester City manager Pep Guardiola has been forced into issuing further comment on his Etihad Stadium future following Enzo Maresca’s exit from Chelsea. Speculation surrounding Guardiola’s ...

This year marked a pivotal moment in the quest to treat Huntington’s disease, a rare but devastating form of dementia. Scientists found that an experimental gene therapy slowed the condition’s ...

Low-Earth orbit (LEO) systems have emerged as a promising complement to GNSS, offering higher received power, better satellite geometry and broader spectrum options. Researchers aim to evaluate ...

As Columbus city government debates whether it can continue funding the Columbus Promise program, how are the students participating in the program performing? On Dec. 10, The Dispatch reported that ...

When Chase Johnson was 31, her dog began acting strange. He was anxious, wouldn’t leave her side and, one day, pushed his nose into the side of her breast. Johnson felt a hard lump. “I wasn’t someone ...

(FOX40.COM) — Governor Gavin Newsom announced on Monday his commitment to housing equity and affordability by awarding the state $181.1 million in funding to focus on helping thousands of low-income ...

A new targeted alpha therapy is showing promise for patients whose thyroid cancer no longer responds to radioactive iodine, the standard beta-emitting treatment. In a first-in-human study, ...

Thirty years ago today, Netscape Communications and Sun Microsystems issued a joint press release announcing JavaScript, an object scripting language designed for creating interactive web applications ...

Despite the considerable disease burden associated with hereditary hemorrhagic telangiectasia, no therapies are licensed for treatment. In a proof-of-concept, placebo-controlled trial, the ...

An error has occurred. Please try again. With a The Portland Press Herald subscription, you can gift 5 articles each month. It looks like you do not have any active ...